Clifford Goodman to Moderate March NCCN Academy
Kelly C. Simpson, Manager, Global Initiatives, Editor, eBulletin: International Edition
Next month, Clifford Goodman, PhD, of The Lewin Group will moderate the NCCN Academy for Excellence & Leadership in Oncology™ School of Pharmaceutical & Biotech Business (NCCN Academy) program which will be held in Hollywood, Florida on March 14. This interactive, 1-day NCCN Academy will commence the day before the NCCN Annual Conference general session begins. NCCN Academy is a program series structured as a forum for pharmaceutical and biotech professionals to learn from key stakeholders about the most pressing issues in oncology today, with the goal that those insights will aid them in creating mutually-successful working relationships.
To open this installment in the NCCN Academy series, issues affecting decision-making will be evaluated from both the academic and community perspectives. Panelists to discuss this hot topic include: Al B. Benson III, MD, of The Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Tim Boozan of Florida Cancer Specialists Foundation; Kirby J. Eng, RPh, of CVS Caremark; James N. Frame, MD, of David Lee Cancer Center; and Raymond J. Muller, MS, RPh, of Memorial Sloan-Kettering Cancer Center.
Representing McKesson Health Solutions, Laura Coughlin, RN, MBA, will discuss guidelines, pathways, and decision-assist tools alongside co-panelists Kirby J. Eng, RPh; C. Lyn Fitzgerald, MJ, of the National Comprehensive Cancer Network; Daniel McCrone, MD, of New Century Health; and Mark S. Rubin, MD, of Florida Cancer Specialists & Research Institute.
Afternoon sessions include Patricia J. Goldsmith of the National Comprehensive Cancer Network presenting on the business side of oncology. This popular module provides clarification and insight into this increasingly pertinent subject. For the closing session, a panel of NCCN experts will be assembled to give attendees the unique opportunity to "Ask the Experts." Ramaswamy Govindan, MD, of Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Robert J. Morgan, Jr., MD, of City of Hope Comprehensive Cancer Center; and John A. Thompson, MD, of Seattle Cancer Care Alliance will be available to address participants' questions about the development of NCCN treatment recommendations, the decision-making process that results in the recommendations included in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), and other areas of interest as expressed by the audience.
In addition to live NCCN Academy programs, NCCN offers select NCCN Academy modules for limited licensing in video format for a period of 12 months that may be used by companies for internal training purposes. If you are interested in customizing an NCCN Academy to meet your companies' specific needs, please visit NCCN.org to submit your inquiry.